Tunicamycin and β-Lactams with Five Membered Ring Structures Have Stronger Synergistic Effects Against Gram-Positive Bacteria

Xueyangyang Bai , Jinjing Xue , Fei He , Xiaotong Yang , Houru Liu , Kuan Gu , Qianghua Lv , Yonglin Zhou

Zoonoses ›› 2025, Vol. 5 ›› Issue (1) : 30

PDF (3980KB)
Zoonoses ›› 2025, Vol. 5 ›› Issue (1) :30 DOI: 10.15212/ZOONOSES-2025-0024
ORIGINAL ARTICLE
research-article
Tunicamycin and β-Lactams with Five Membered Ring Structures Have Stronger Synergistic Effects Against Gram-Positive Bacteria
Author information +
History +
PDF (3980KB)

Abstract

Objective: The prevalence of antimicrobial resistance is increasing among gram-positive bacteria, particularly the resistance of methicillin-resistant Staphylococcus aureus (MRSA) to β-lactam antibiotics.

Methods: Checkerboard minimum inhibitory concentration (MIC) assays, time-killing assays, enzyme inhibition assays, hemolysis tests, and cytotoxicity analyses were performed to confirm the synergistic effects of tunicamycin (TUN) in combination with β-lactam antibiotics at levels without potential cytotoxicity.

Results: TUN at ≤ 1 μg/mL decreased the MICs of cephalosporins or penicillins against MRSA strain USA300, which became sensitive. TUN showed synergistic effects with cefuroxime sodium (FIC index ≤ 0.19) against tested gram-positive bacterial strains of both human clinical and animal origin. Time-killing assays indicated that the combination treatment eliminated MRSA 3–9 h after inoculation. Furthermore, we confirmed the better synergy of specific β-lactam antibiotics at potentially cytotoxicity-free concentrations in combination with TUN against β-lactam-resistant gram-positive microorganisms.

Conclusion: This study provides an experimental basis for combination treatment with TUN and β-lactam antibiotics with specific chemical structures for the clinical treatment of gram-positive bacterial infections.

Keywords

Tunicamycin / β-lactam antibiotics / methicillin-resistant Staphylococcus aureus / anti-infection

Cite this article

Download citation ▾
Xueyangyang Bai, Jinjing Xue, Fei He, Xiaotong Yang, Houru Liu, Kuan Gu, Qianghua Lv, Yonglin Zhou. Tunicamycin and β-Lactams with Five Membered Ring Structures Have Stronger Synergistic Effects Against Gram-Positive Bacteria. Zoonoses, 2025, 5 (1) : 30 DOI:10.15212/ZOONOSES-2025-0024

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Okeke IN, de Kraker MEA, Van Boeckel TP, Kumar CK, Schmitt H, Gales AC, et al. The scope of the antimicrobial resistance challenge. Lancet. 2024; 403(10442): 2426-2438.

[2]

Wang TZ, Kodiyanplakkal RPL, Calfee DP. Antimicrobial resistance in nephrology. Nat Rev Nephrol. 2019; 15(8): 463-481.

[3]

McEwen SA, Collignon PJ. Antimicrobial resistance: a one health perspective. Microbiol Spectr. 2018; 6(2): 1-26.

[4]

Belete MA, Gedefie A, Alemayehu E, Debash H, Mohammed O, Gebretsadik D, et al. The prevalence of vancomycin-resistant Staphylococcus aureus in Ethiopia: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2023; 12(1): 86.

[5]

Ebakota DO, Abiodun OA, Nosa OO. Prevalence of antibiotics resistant Listeria monocytogenes strains in Nigerian ready-to-eat foods . Food Saf (Tokyo). 2018; 6(3): 118-125.

[6]

Baquero F, F Lanza V, Duval M, Coque TM. Ecogenetics of antibiotic resistance in Listeria monocytogenes. Mol Microbiol. 2020; 113(3): 570-579.

[7]

Vestergaard M, Frees D, Ingmer H. Antibiotic resistance and the MRSA problem. Microbiol Spectr. 2019; 7(2): 1-23.

[8]

Jiang JH, Cameron DR, Nethercott C, Aires-de-Sousa M, Peleg AY. Virulence attributes of successful methicillin-resistant Staphylococcus aureus lineages . Clin Microbiol Rev. 2023; 36(4): e0014822.

[9]

Turner NA, Sharma-Kuinkel BK, Maskarinec SA, Eichenberger EM, Shah PP, Carugati M, et al. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol. 2019; 17(4): 203-218.

[10]

Bush K, Bradford PA . β-lactams and β-lactamase inhibitors: an overview. Cold Spring Harb Perspect Med. 2016; 6(8): a025247.

[11]

Yamamoto K, Ichikawa S. Tunicamycin: chemical synthesis and biosynthesis. J Antibiot (Tokyo). 2019; 72(12): 924-933.

[12]

Eckardt K. Tunicamycins, streptovirudins, and corynetoxins, a special subclass of nucleoside antibiotics. J Nat Prod. 1983; 46(4): 544-550.

[13]

Mann PA, Müller A, Wolff KA, Fischmann T, Wang H, Reed P, et al. Chemical genetic analysis and functional characterization of Staphylococcal wall teichoic acid 2-epimerases reveals unconventional antibiotic drug targets. PLoS Pathog. 2016; 12(5): e1005585.

[14]

Zhou Y, Guo Y, Sun X, Ding R, Wang Y, Niu X, et al. Application of oleanolic acid and its analogues in combating pathogenic bacteria in vitro/vivo by a two-pronged strategy of β-lactamases and hemolysins. ACS Omega. 2020; 5(20): 11424-11438.

[15]

Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008; 3(2): 163-175.

[16]

Humphries R, Bobenchik AM, Hindler JA, Schuetz AN. Overview of changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition . J Clin Microbiol. 2021; 59(12): e0021321.

[17]

Wang N, Li W, Yu H, Huang W, Qiao Y, Wang Q, et al. Laurocapram, a transdermal enhancer, boosts cephalosporin’s antibacterial activity against Methicillin-resistant Staphylococcus aureus. Biochem Pharmacol. 2024; 227: 116404.

[18]

Claus B, Buyle F, Robays H, Vogelaers D. Importance of infusion volume and pump characteristics in extended administration of ß-lactam antibiotics. Antimicrob Agents Chemother. 2010; 54(11): 4950.

[19]

Foster TJ. Can β-lactam antibiotics be resurrected to combat MRSA? Trends Microbiol. 2019; 27(1): 26-38.

[20]

Hornish RE, Kotarski SF. Cephalosporins in veterinary medicine - ceftiofur use in food animals. Curr Top Med Chem. 2002; 2(7): 717-731.

[21]

Justiz Vaillant AA, Vashisht R, Zito PM. Immediate hypersensitivity reactions (archived). 2023 May 29. In StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2025.

[22]

Dong YY, Wang H, Pike ACW, Cochrane SA, Hamedzadeh S, Wyszynski FJ, et al. Structures of DPAGT1 explain glycosylation disease mechanisms and advance TB antibiotic design. Cell. 2018; 175(4): 1045-1058.e16.

[23]

Price NPJ, Jackson MA, Singh V, Hartman TM, Blackburn JA, Dowd PF. Synergistic enhancement of beta-lactam antibiotics by modified tunicamycin analogs TunR1 and TunR2. J Antibiot (Tokyo). 2019; 72(11): 807-815.

[24]

Kunz Coyne AJ, Stamper K, Bleick C, Kebriaei R, Lehman SM, Rybak MJ . Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms. Microbiol Spectr. 2024; 12(4): e0321223.

[25]

Wang Y, Zhang P, Wu J, Chen S, Jin Y, Long J, et al. Transmission of livestock-associated methicillin-resistant Staphylococcus aureus between animals, environment, and humans in the farm. Environ Sci Pollut Res Int. 2023; 30(37): 86521-86539.

PDF (3980KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/